Hence, non-viral delivery methods have received great interest recently; for instance, gold nanoparticles have been used to deliver Cas9 ribonucleoproteins targeting mGluR5 in a mouse model of fragile X syndrome (12). This evidence concerns the gene GRM5 and fragile X syndrome.